The ASC market’s revenues, Dr. Farid Namin’s PPE manufacturer and more — 4 GI industry notes

Here are four updates from GI practices and companies over the past week:

Advertisement

1. The gastroenterology ASC market had revenues of $7.21 billion in 2019 and has $10.27 billion in its sights for 2027.

2. Exact Sciences provided the Kentucky Department for Public Health a grant for 1,000 Cologuard kits.

3. Gastroenterologist Farid Namin, MD, opened a personal protective equipment manufacturer after overcoming procurement obstacles early in the pandemic.

4. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test.

More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.